{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:23:58Z","timestamp":1794025438801,"version":"4.8.0"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,11,1]]},"DOI":"10.2169\/internalmedicine.6567-25","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:08:44Z","timestamp":1773698924000},"page":"2813-2823","source":"Crossref","is-referenced-by-count":0,"title":["Relationship between &lt;i&gt;Clostridioides difficile&lt;\/i&gt; Infections and Antimicrobial Use in Patients with Hematopoietic Diseases"],"prefix":"10.2169","volume":"65","author":[{"given":"Kazuki","family":"Inai","sequence":"first","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Marumo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Washio","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Shinoyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yui","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Czepiel J, Dr\u00f3\u017cd\u017c M, Pituch H, et al. <i>Clostridium difficile<\/i> infection: review. Eur J Clin Microbiol Infect Dis 38: 1211-1221, 2019.","DOI":"10.1007\/s10096-019-03539-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kunishima H, Ohge H, Suzuki H, et al. Japanese Clinical Practice Guidelines for Management of <i>Clostridioides<\/i> (<i>Clostridium<\/i>) <i>difficile<\/i> infection. J Infect Chemother 28: 1045-1083, 2022.","DOI":"10.1016\/j.jiac.2021.12.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of <i>Clostridioides difficile<\/i> infection in adults. Clin Infect Dis 73: e1029-e1044, 2021.","DOI":"10.1093\/cid\/ciab549"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for <i>Clostridium difficile<\/i> infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66: 987-994, 2018.","DOI":"10.1093\/cid\/ciy149"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. P\u00e9pin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for <i>Clostridium difficile<\/i>-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41: 1254-1260, 2005.","DOI":"10.1086\/496986"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Huang SC, Yang YJ, Lee CT. Rectal prolapse in a child: an unusual presentation of <i>Clostridium difficile<\/i>-associated pseudomembranous colitis. Pediatr Neonatol 52: 110-112, 2011.","DOI":"10.1016\/j.pedneo.2011.02.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dutta D, Jafri F, Stuhr D, Knoll BM, Lim SH. A contemporary review of <i>Clostridioides difficile<\/i> infections in patients with haematologic diseases. J Intern Med 289: 293-308, 2021.","DOI":"10.1111\/joim.13173"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bucaneve G, Micozzi A, Menichetti F, et al.; the Gruppo Italiano Malattie Ematologiche dell&apos;Adulto (GIMEMA) Infection Program. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353: 977-987, 2005.","DOI":"10.1056\/NEJMoa044097"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Daniels LM, Durani U, Barreto JN, et al. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia. Support Care Cancer 27: 4171-4177, 2019.","DOI":"10.1007\/s00520-019-04701-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gweon TG, Choi MG, Baeg MK, et al. Hematologic diseases: high risk of <i>Clostridium difficile<\/i> associated diarrhea. World J Gastroenterol 20: 6602-6607, 2014.","DOI":"10.3748\/wjg.v20.i21.6602"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15: e538-e548, 2014.","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Slimings C, Riley TV. Antibiotics and healthcare facility-associated <i>Clostridioides difficile<\/i> infection: systematic review and meta-analysis 2020 update. J Antimicrob Chemother 76: 1676-1688, 2021.","DOI":"10.1093\/jac\/dkab091"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kanda Y. Investigation of the freely available easy-to-use software &apos;EZR&apos; for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Murphy MM, Patatanian E, Gales MA. Extended duration vancomycin in recurrent <i>Clostridium difficile<\/i> infection: a systematic review. Ther Adv Infect Dis 5: 111-119, 2018.","DOI":"10.1177\/2049936118798276"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Umemura T, Ota A, Mutoh Y, et al. Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent <i>Clostridioides difficile<\/i> infection in the Japanese setting: a case control study. J Pharm Health Care Sci 5: 19, 2019.","DOI":"10.1186\/s40780-019-0147-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rajakumar I, Jaber R, Ali R, Rennert-May E, Sabuda D. Impact of <i>Clostridioides difficile<\/i> length of treatment on rates of recurrence in patients on concurrent antibiotics. Am J Infect Control 51: 1213-1217, 2023.","DOI":"10.1016\/j.ajic.2023.04.167"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kwiatkowski D, Marsh K, Katz A, et al. Impact of oral vancomycin treatment duration on rate of <i>Clostridioides difficile<\/i> recurrence in patients requiring concurrent systemic antibiotics. Infect Control Hosp Epidemiol 45: 717-725, 2024.","DOI":"10.1017\/ice.2024.4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shin JW, Yong D, Kim MS, et al. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin. J Infect Chemother 9: 62-67, 2003.","DOI":"10.1007\/s10156-002-0215-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49: 1373-1379, 1996.","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent <i>Clostridium difficile<\/i> infection. J Hosp Infect 70: 298-304, 2008.","DOI":"10.1016\/j.jhin.2008.08.012"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Abou Chakra CN, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in <i>Clostridium difficile<\/i> infection: a systematic review. PLoS ONE 9: e98400, 2014.","DOI":"10.1371\/journal.pone.0098400"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Eze P, Balsells E, Kyaw MH, Nair H. Risk factors for <i>Clostridium difficile<\/i> infections - an overview of the evidence base and challenges in data synthesis. J Glob Health 7: 010417, 2017.","DOI":"10.7189\/jogh.07.010417"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of <i>Clostridium difficile<\/i> infection. N Engl J Med 320: 204-210, 1989.","DOI":"10.1056\/NEJM198901263200402"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fatima R, Aziz M. The hypervirulent strain of Clostridium difficile: NAP1\/B1\/027 - a brief overview. Cureus 11: e3977, 2019.","DOI":"10.7759\/cureus.3977"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tenover FC, Baron EJ, Peterson LR, Persing DH. Laboratory diagnosis of <i>Clostridium difficile<\/i> infection. J Mol Diag 13: 573-582, 2011.","DOI":"10.1016\/j.jmoldx.2011.06.001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mani S, Rybicki L, Jagadeesh D, Mossad SB. Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant 51: 713-717, 2016.","DOI":"10.1038\/bmt.2015.311"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_6567-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:33:06Z","timestamp":1794022386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_6567-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":26,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6567-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,1]]},"article-number":"6567-25"}}